Barriers to Widespread Access to Cancer Medications Include Excessive Cost
By Elana Gotkine HealthDay Reporter
TUESDAY, Nov. 19, 2024 -- Barriers to widespread access to cancer treatments include excessive cost and lack of affordability, according to a review published online Nov. 18 in Cancer.
Arafat H. Tfayli, M.D., from the American University of Beirut Medical Center, and colleagues conducted a systematic review to examine the current state of cancer drug development, assessing the availability of drugs in different income countries.
The researchers note that an increase in cancer cases worldwide is projected, especially in low-income countries, where most cancer-related deaths are expected. The approval rate of cancer treatments has increased, but significant barriers to widespread access are posed by their excessive cost and lack of affordability. Geographic location and procurement connections influence disparities in the costs of crucial cancer medications. Sharing production secrets, implementing price discrimination, international funding, improved primary health care measures, and implementation of cost-effective screening methods are potential solutions for addressing the inequity in drug distribution.
"Accessibility to effective cancer treatments needs to become a fundamental human right that transcends borders and one that could become economically affordable. All parties should collaborate to ensure that the principle of beneficence is well applied," the authors write. "In the 21st century, it cannot and should not be a medical disadvantage to be born in a low‐income country."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Posted November 2024
Read this next
Declining Childhood Vaccination May Increase Risk for Vaccine-Preventable Infections
WEDNESDAY, April 30, 2025 -- Declining childhood vaccination rates may increase outbreaks of eliminated vaccine-preventable infections within the United States, leading to a...
AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer
TUESDAY, April 29, 2025 -- Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, according to a study presented...
AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors
TUESDAY, April 29, 2025 -- A neoadjuvant programmed cell death 1 (PD-1) blockade enables nonoperative management among patients with early-stage mismatch repair-deficient (dMMR)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.